Erythema Infectiosum Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Parvovirus B19 Infection in Hereditary Hemolytic Anemias Patients
Condition: Parvovirus B19 Infection Intervention: Other: Supportive treatment with or without red cell transfusion/intravenous immune globulin (IVIG) Sponsors: Sohag University; Assiut University Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 30, 2021 Category: Research Source Type: clinical trials
A New Reagent Assay Examining Natural Parvovirus B19 Infection in Sickle Cell Disease
Condition: Sickle Cell DiseaseInterventions: Other: Blood draw; Other: Nasopharyngeal washSponsors: St. Jude Children's Research Hospital; Novartis Vaccines; National Heart, Lung, and Blood Institute (NHLBI)Not yet recruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 9, 2014 Category: Research Source Type: clinical trials
A New Reagent Assay Examining Natural Parvovirus B19 Infection in Sickle Cell Disease
Condition: Sickle Cell DiseaseInterventions: Other: Blood draw; Other: Nasopharyngeal washSponsors: St. Jude Children's Research Hospital; Novartis Vaccines; National Heart, Lung, and Blood Institute (NHLBI)Recruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 9, 2014 Category: Research Source Type: clinical trials
Intravenous Immunoglobulin (IVIg) for Parvovirus B19(PVB19) Mediated Cardiomyopathy
Conditions: Myocardial Diseases; PVB19Interventions: Drug: Intravenous Immunoglobulins; Drug: plasma volume expanderSponsor: SanquinRecruiting - verified January 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 1, 2009 Category: Research Source Type: clinical trials